Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa

dc.contributor.authorJacobson K.R.
dc.contributor.authorTheron D.
dc.contributor.authorVictor T.C.
dc.contributor.authorStreicher E.M.
dc.contributor.authorWarren R.M.
dc.contributor.authorMurray M.B.
dc.date.accessioned2011-10-13T16:59:43Z
dc.date.available2011-10-13T16:59:43Z
dc.date.issued2011
dc.description.abstractWe report treatment outcomes from a retrospective cohort of patients with isoniazid-monoresistant tuberculosis in rural South Africa. Sixteen percent of patients had poor outcomes, 61% of whom progressed to multidrug-resistant tuberculosis. These data reveal the need for early identification and aggressive follow-up of isoniazid monoresistance to increase treatment success. © The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
dc.description.versionArticle
dc.identifier.citationClinical Infectious Diseases
dc.identifier.citation53
dc.identifier.citation4
dc.identifier.citationhttp://www.scopus.com/inward/record.url?eid=2-s2.0-79961212199&partnerID=40&md5=899788a72dcd59e189b2d20dd01e1294
dc.identifier.issn10584838
dc.identifier.other10.1093/cid/cir406
dc.identifier.urihttp://hdl.handle.net/10019.1/17218
dc.titleTreatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa
dc.typeArticle
Files